阿立哌唑与利培酮治疗老年期精神分裂症对照研究
被引量:1
摘要
为探讨阿立哌唑对老年期精神分裂症的疗效和安全性,将阿立哌唑与利培酮进行临床对照研究,现报告如下:
出处
《中国民康医学》
2009年第20期2491-2491,共1页
Medical Journal of Chinese People’s Health
二级参考文献16
-
1Shapiro DA, Renoch S, Arrington E, et al. Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology[ J ]. Neuropsychopharmacology, 2003,28 ( 8 ):1 400.
-
2Kane JM, Carson WH, Saha AR, et al. Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder [ J ]. J Clin Psychiatry, 2002,63(9) :763.
-
3Potkin SG, Saha AR, Kujawa MJ, et al. Aripipazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder [ J ]. Arch Gen Psychiatry, 2003,60(7) :681.
-
4Kern RS, Cornblatt B, Carson WH, et al. An open - label comparison of the neurocognitive effects of aripiprazole vs olanzapine in patients with stable psychosis [ J ]. Schizophr Res, 2001,49(suppl 1 - 2) :s234.
-
5Van Vliet BJ, Mos J, Vander Heijden JAM, et al. DU 127090:a highly potent, atypical dopamine receptor ligand- a putative potent full spectrum antipsychotic with low EPS potential[J]. Eur Neuropsychopharmacol, 2000, 10(suppl 3):s293.
-
6Hesselink MB, Van Vliet BJ, Ronken E, et al. DU 127090:a novel partial dopamine agonist with antipsychotic activity.High potency but low efficacy at dopamine D2 receptors [ J ].Schizophrenia Research, 2003, 60( 1 ): 108.
-
7De Vries MH, Vdo de Haes J, Long SK, et al. DU127090: a highly potent, atypical dopamine receptor ligand: pilot study of dopamine D2 receptor occupancy after multiple oral administration of DU 127090 to healthy male volunteers, using 11C - rac lopride by means of positron emission tomography [J]. Eur Neuropsychopharmacol, 2000, 10(suppl 3): s294.
-
8Lahti AC, Weiler MA, Corey PK, et al. Antipsychotic properties of the partial agonist ( - ) - 3 - (3 -hydroxyphenenyl) - N - propylpiperidine (preclamol) in schizophrenia[J]. Biol Psychiatry, 1998, 43:2.
-
9Meltzer LT, Christoffersen CL, Ceobin AE, et al. CI1007, a dopamine partial agonist agent [ J ]. J Pharmacol Exp Thep,1995, 274:912.
-
10Benkert O, Muller Siecheneder F, Wetzel H. Dopamine agonists in schizophrenia: a review [ J ]. Eur Neuropsychopharmacol, 1995, 5(suppl): 43.
共引文献34
-
1王晓华.博思清与氯氮平治疗精神分裂症对照研究[J].四川医学,2005,26(9):982-983. 被引量:2
-
2王晓华.阿立哌唑与利培酮治疗精神分裂症对照研究[J].江西医药,2005,40(11):752-753. 被引量:2
-
3杨凤茹,钟昆.阿立哌唑与利培酮治疗精神分裂症的疗效对照分析[J].四川精神卫生,2006,19(2):84-86. 被引量:9
-
4王东平,李予春,冯砚国,卫世强,卢爱莲,张铁松.阿立哌唑与利培酮治疗精神分裂症对照研究[J].临床心身疾病杂志,2006,12(4):245-246. 被引量:15
-
5谢维爵,赵毅民,李俊,周娅,陈姝.阿立哌唑与氯氮平治疗躁狂症的对照研究[J].山东精神医学,2006,19(3):218-219. 被引量:7
-
6吴文友,肖秉林,蔡廷林.“四导三疑一创”课堂教学模式研究[J].教学与管理(中学版),2002(12):64-65.
-
7付小惠,安桂淑.阿立哌唑治疗精神分裂症临床观察[J].中国民康医学,2007,19(5):201-201. 被引量:5
-
8杨莉,胡怡,张轶杰,周丽萍,杨爽艺.阿立哌唑与利培酮治疗精神分裂症的疗效对照分析[J].西部医学,2007,19(5):888-889. 被引量:2
-
9陈海支,俞柏润,杨身国,沈仲夏,糜屈,蒋永红.阿立哌唑对舒必利所致高催乳素血症的影响[J].医药导报,2007,26(10):1145-1146. 被引量:1
-
10卢迪冰,李杰,万蓉.阿立哌唑与氯丙嗪治疗精神分裂症的对照研究[J].宜春学院学报,2007,29(6):123-123.
同被引文献5
-
1曹雷,张虹,周磊.联合西酞普兰治疗以阴性症状为主的精神分裂症56例疗效分析[J].吉林大学学报(医学版),2011,37(6):1132-1132. 被引量:1
-
2陈姝,张映霞.阿立哌唑治疗脑器质性精神障碍疗效观察[J].临床精神医学杂志,2012,17(14):140-141,153.
-
3潘继英,全传升,张淑芬.阿立哌唑与利培酮治疗精神分裂症对照研究[J].临床精神医学杂志,2012,17(12):70-71,160-163.
-
4白锦波.阿立哌唑治疗精神分裂症的临床效果分析[J].华北煤炭医学院学报,2010,12(1):141-141. 被引量:2
-
5蔡明.脑器质性精神障碍应用阿立哌唑的临床观察[J].中国实用神经疾病杂志,2010,13(21):74-74. 被引量:5
-
1应益飞,徐松泉,留晓霞,叶剑辉,曹江.米氮平与氟西汀治疗抑郁症临床对照研究[J].现代中西医结合杂志,2007,16(20):2834-2835.
-
2李敬.瑞舒伐他汀与阿托伐他汀治疗冠心病临床对照研究[J].数理医药学杂志,2015,28(6):887-888. 被引量:6
-
3吴凡,谢宪平.艾司西酞普兰合并奥氮平治疗老年抑郁症的临床对照研究[J].中国医药指南,2016,14(31):81-81. 被引量:2
-
4张锁林,赵玉杰,王周勋,宋华安,宋允章.再发缺血性脑血管病临床对照研究[J].中国慢性病预防与控制,2000,8(2):90-90. 被引量:1
-
5印豪,朱文清.氨氯地平和硝苯地平治疗原发性高血压的临床对照研究[J].中国实用内科杂志,1998,18(8):506-507. 被引量:10
-
6丁志杰.齐拉西酮与氯丙嗪治疗精神分裂症临床对照研究[J].精神医学杂志,2008,21(1):42-43. 被引量:8
-
7陈庆学,杨秀成,何呈刚.帕罗西汀和丁螺环酮治疗广泛性焦虑症临床对照研究[J].社区医学杂志,2011,9(8):82-83. 被引量:5
-
8王正午.帕罗西汀治疗抑郁症的临床对照研究[J].继续医学教育,1999,13(3):44-46. 被引量:3
-
9黎志峰.多索茶碱与氨茶碱治疗慢性阻塞性肺疾病临床对照研究[J].按摩与康复医学,2015,6(17):78-78.
-
10王元芳.利培酮与奋乃静治疗老年期精神分裂症的临床对照研究[J].中国中医药咨讯,2009,1(4):26-26.